[Special Stock] Green Cross Holdings 2 Preferred Hits Record High on Affiliate Performance Improvement and Commercial Act Amendment Expectations

Green Cross Holdings 2 Preferred shares are showing strong gains in early trading.

As of 9:05 a.m. on June 10, Green Cross Holdings 2 Preferred shares were trading at 66,400 won, up 13.70% (8,000 won) from the previous day, marking a new 52-week high. The stock has been on a rising streak for seven consecutive trading days, and in the past two sessions, it even hit the daily upper limit during intraday trading.

Investor sentiment appears to have been boosted by analysis from the previous day in the securities market, which suggested that Green Cross Holdings is set to accelerate its transformation into a full-cycle healthcare company this year, driven by improved performance among major listed affiliates and the listing of GC Genome.

Wi Haejoo, a researcher at Korea Investment & Securities, stated, "GC Cell, which previously posted significant losses, plans to reduce its research expenses by about 6 billion won this year by reprioritizing its R&D pipeline and securing government projects. GC Wellbeing is expected to continue its growth based on Laennec, a placenta injection product." He also projected, "Sales channels will expand through the start of sales in Hainan, China, the addition of intravenous administration methods, and the introduction of high-capacity vial formulations." Regarding another affiliate, UBcare, he forecast increased software sales driven by expanded dominance in the EMR (Electronic Medical Records) market and growth in products such as UBIST (an outpatient prescription drug analysis tool).

Green Cross Holdings, the first pharmaceutical holding company in Korea, oversees the management strategies and operations of a total of 56 affiliates (32 domestic and 24 overseas), with GC Green Cross as its flagship. The push for amendments to the Commercial Act by President Lee Jaemyung, which has brought holding companies and preferred shares into the spotlight as beneficiaries, is also cited as a factor driving the share price higher.

This content was produced with the assistance of AI translation services.